André Arigony SOUTO,Diógenes Santiago SANTOS,LUIZ AUGUSTO BASSO,MARIA MARTHA CAMPOS,Natália Fontana NICOLETTI
申请号：
IN2386/MUMNP/2012
公开号：
IN2012MN02386A
申请日:
2012.10.12
申请国别(地区):
IN
年份:
2013
代理人:
摘要：
The present invention describes a pharmaceutical formulation and a process for avoiding and/or reducing hepatotoxicity associated with the treatment of tuberculosis decreasing the time of treatment and avoiding resistant strains of Mycobacterium tuberculosis. The pharmaceutical formulation of the present invention comprises resveratrol a tuberculostatic compound and a pharmaceutically acceptable carrier. The present invention lies in the fields of chemistry pharmacy and medicine.
